Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
UBS Group Ag ADR
(NY:
UBS
)
31.80
+0.06 (+0.19%)
Official Closing Price
Updated: 7:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about UBS Group Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
Signs of life: Are wealthy investors warming to ESG again?
October 18, 2024
A recent uptick in capital flowing into environmental, social, and governance (ESG) funds has left some financial advisors hopeful that interest in the
Via
Equities.com
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,800 Today
October 18, 2024
Via
Benzinga
Join Gorilla Technology's Exclusive Live Investor Webinar and Q&A Session on October 24
October 18, 2024
London, United Kingdom--(Newsfile Corp. - October 18, 2024) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company") is...
Via
Newsfile
Advisor John Hardin Joins UBS Private Wealth Management in Miami
October 17, 2024
From
UBS
Via
Business Wire
Financial Advisor James Kosan joins UBS in the Inland Empire
October 15, 2024
From
UBS
Via
Business Wire
Looking Into UBS Gr's Recent Short Interest
October 04, 2024
Via
Benzinga
UBS Celebrates 16th Year as Presenting Sponsor of Art San Diego and Continues Philanthropic Access to Art Program Benefitting Monarch School Students
October 16, 2024
From
UBS
Via
Business Wire
UBS Financial Advisor Warren Coughlin Named to the Forbes Top Next-Gen Best-in-State Wealth Advisor List
October 15, 2024
From
UBS
Via
Business Wire
Global Markets Navigate UBS Forecasts, Geopolitical Tensions, And Oil Price Shifts Amid Economic Uncertainty
October 15, 2024
As markets react to economic forecasts, geopolitical developments, and strategic corporate moves, today’s headlines highlight the complexities shaping the global landscape.
Via
Talk Markets
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
September 25, 2024
Via
Benzinga
Peering Into UBS Gr's Recent Short Interest
September 18, 2024
Via
Benzinga
Green stocks stumble as markets price in marginal polling improvements for Trump
October 11, 2024
Prominent Democratic leaders in swing states, including Michigan and Wisconsin, have raised concerns over the last week over improved polling for former
Via
Equities.com
Topics
ETFs
Government
Exposures
Political
Five UBS Financial Advisors in the Pacific Desert Market Recognized by Forbes as Top Next-Gen Advisors
October 09, 2024
From
UBS
Via
Business Wire
Three Strong Reasons To Buy NXP Stock After UBS Upgrade
October 07, 2024
The stock is well positioned for recovery in 2025, making it an attractive choice among its peers.
Via
Talk Markets
UBS Declares Coupon Payments on 14 ETRACS Exchange Traded Notes
October 07, 2024
From
UBS
Via
Business Wire
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) CEO to Participate in Fireside Cat at UBS Virtual Organ Restoration and Cell Therapy Day
October 07, 2024
Via
Investor Brand Network
The S&P 500 Just Did Something for the 1st Time This Century. History Says the Stock Market Will Do This Next.
October 07, 2024
The S&P 500 just delivered its best year-to-date return through September since 1997.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Gold Breakout In CHF: UBS Recommends Allocating 5% Of Your Portfolio To The Yellow Metal
October 04, 2024
Gold has finally broken through resistance in Swiss francs, setting a new monthly closing record in September.
Via
Talk Markets
UBS Hires $400 Million Financial Advisor Team in Manchester, NH
October 04, 2024
From
UBS
Via
Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
September 13, 2024
Via
Benzinga
The S&P 500 Just Had Its Best September in 11 Years. History Says the Stock Market Will Do This Next.
October 04, 2024
The stock market had an unexpectedly good September, and momentum could carry the S&P 500 higher in the fourth quarter.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
OpenAI Secures $4B Credit Line To Supercharge AI Ambitions And Expand Nvidia-Powered Infrastructure: 'Provides Flexibility To Seize Future Growth Opportunities'
October 03, 2024
OpenAI secured a $4 billion revolving credit line, boosting its liquidity to $10 billion, which will support investments in high-cost computing infrastructure, including Nvidia chips.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 Supercharged Growth Stocks to Buy Before They Soar as Much as 169% According to Select Wall Street Analysts
September 28, 2024
The stock market has been on a breathtaking run, but some stocks have additional upside ahead, according to Wall Street.
Via
The Motley Fool
1 Artificial Intelligence Stock Down 43% Set to Soar 100% by 2026, According to Wall Street
September 25, 2024
The memory leader reports earnings today.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nike Executive Returning To Become Top Leader Continues 'Boomerang CEO' Trend At Major Companies
September 20, 2024
Nike appoints Elliott Hill, former president, as new CEO, following a trend of 'Boomerang CEOs' returning to top leadership roles in big companies.
Via
Benzinga
UBS Hires Financial Advisor Team in Bethesda, Maryland
September 13, 2024
From
UBS
Via
Business Wire
Chief Growth Officer at The Zeitgeist, Ryan Hall, Helps Businesses to Identify and Seize Growth Opportunities
September 13, 2024
Via
Press Release Distribution Service
Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
September 12, 2024
Apple's new AI-capable iPhone 16 is about to hit the shelves. Is the release the beginning of a "super-cycle" in iPhone sales?
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's Going With UBS Shares On Wednesday?
September 11, 2024
UBS reaffirms commitment to Swiss market, to maintain $414B in loans despite rumors of cuts.
Via
Benzinga
Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
September 10, 2024
UBS has initiated coverage on Harmony Biosciences with a Buy rating and a price target of $56. UBS highlights Harmony's potential for growth, projecting a 19% CAGR for Wakix sales through 2026.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
43
44
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.